Who we are
Epidemiology Coordinating and Research (EPICORE) Centre is a clinical trials and health services research centre.
EPICORE Centre is involved in the full range of activities necessary for the conduct of clinical trials, including protocol design, case report forms design, database creation, study management, implementation, site coordination (for multicentre trials), data management, and analysis.
We are involved in a large number of single centre, and multicentre trials. EPICORE Centre is also the home of the Centre for Community Pharmacy Research and Interdisciplinary Strategies (COMPRIS).
To serve the Faculty and our community by generating new knowledge in the areas of health and health care through the design, execution and analysis of clinical trials, health outcomes research and epidemiologic studies.
RxOUTMAP tracks and quantifies the impact of pharmacist management of patients with uncomplicated urinary tract infections. Urinary tract infections (UTIs) are common infections that may be very unpleasant for patients and have the potential to lead to complications. They are also commonly misdiagnosed and treated inappropriately, resulting in unnecessary antimicrobial exposure and increased potential for […]
ABLE cGVHD – Applied Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease in Late Effects of Childhood Cancer
ABLE Cisplatin Ototoxicity and Nephrotoxicity Biomarkers: a project of the Applying Biomarkers to Long-term Effects of Childhood/Adolescent Cancer Treatment Team
This study will evaluate if the use of prebiotics is effective and tolerable for prevention of relapses in ulcerative colitis as well as to determine their protective mechanisms.
Vancomycin’s objective is to determine if using topical vancomycin as a prophylactic treatment during open heart surgery will reduce the incidence of sterna wound infection (SWI).
The goal of this branch of ABLE is to determine the relationship of biomarkers to risk of thrombosis events in a large cohort of Canadian survivors of childhood cancer. As well, to determine other risk factors for thrombosis in a large cohort of Canadian survivors of childhood cancer.
The goal of this study is to evaluate quality of life of patients with atrial fibrillation (AF) whose care is managed by a Nurse Practioner (NP) vs. standard cardiologist care.
Canadian Health Advanced by Nutrition and Graded Exercise (CHANGE) is a multidisciplinary intervention integrating lifestyle intervention into existing primary care settings in Alberta.
The overall study objective for INFORM is to evaluate the state of nutrition care and patient related outcomes in patients with foregut tumors in North American, Europe and Australia.
Click HERE to access the RxING Practice Tool. In 2013, the original RxING study, entitled “Pharmacist intervention for glycemic control in the community,” was the first to investigate independent prescribing by pharmacists for diabetes care. Pharmacists systemically identified patients with poor glycemic control, prescribed insulin, and provided intensive education and support to attain adherence. […]
This study seeks to evaluate the effect of Nurse-Practitioner-led care for people with multiple sclerosis (MS), upon patient levels of depression and anxiety as compared to community neurologist outpatient standard care.
What our clients say
“I was introduced to Ross Tsuyuki and the EPICORE Centre through the University Hospital Foundation, to help with development of a clinical trial to examine the impact and effectiveness of introducing a nurse practitioner for treatment of people with multiple sclerosis. The experience of working with EPICORE to develop a MS clinical trial, come up with relevant outcome measures, considering practicalities of clinical trial logistics has been invaluable to a clinician such as myself. EPICORE has provided the support and structure to design, then carry out a clinical trial. We will be starting trial recruitment in the upcoming few months, and I am confident that we will meet our goals and provide valuable outcomes that are useful in the health care delivery to MS patients.”
Study Title: Nurse Practitioner Management of Multiple Sclerosis in the Community
“EPICORE was responsible for designing the final CRFs, development of the database, interacting with the sites for data submission and entering the data into the database. To date, the recruitment closed as of September 2016 and the CRF data is entered. The laboratory data will be transferred over in the near future.”
Study Title: Applied Biomarkers in Late Effects of Childhood Cancer Study Group: Relationship of Prothrombotic Markers to Thrombosis in Survivors of Childhood Cancer
“I wanted to have a ‘picture’ of the pain profile of our study participants. The EPICORE staff rose to the challenge and were able to find the right resources. Thank you!”
Study Title: Presentation of acute coronary syndromes in White, South Asian, and Chinese patients: An international cohort study
“Our team has been very pleased with EPICORE’s statistical expertise. They
were able to provide independent verification of the results of our
randomised control trial, “Implementation and evaluation of the 5As of
obesity management in primary care,” and to help us create an excellent
format for the statistical presentation. Their assistance in formulating the
statistical responses to peer review simplified that process. We will certainly
use their skills in future projects.”
“Our whole team appreciates the way that Dr. Tsuyuki and his staff have
helped us through the planning, management and analytical aspects of
dealing with our precious data. They are always attentive to the nuances of
our projects and patient with the investigators, staff and students involved.
They are helping us to overcome some tremendous hurdles and make our
projects the very best.”
“Although it took us a while to get INFORM off the ground, working with
your team has been a pleasure – Lily in particular is responsive and on point
– I think we are going to position ourselves – with EPICORE’s help to be able
to gather and analyze this international data set in a very meaningful way.
thanks so much!”